Skip to content

Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test

Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06953024
Enrollment
120
Registered
2025-05-01
Start date
2025-06-30
Completion date
2026-12-31
Last updated
2025-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiv, Syphilis

Brief summary

This study aims to validate the percent agreement of the INSTI Multiplex Human Immunodeficiency (HIV) 1/2 syphilis antibody (Ab) test (INSTI POCT) when used as a self-test by patients compared to conventional serologic testing.

Interventions

DIAGNOSTIC_TESTINSTI HIV/syphilis Point of Care Self-Test Administration

The INSTI Human Immunodeficiency Virus (HIV)/syphilis POCT is a rapid, single-use, flow-through immunoassay that is Health Canada-approved as a screening test for detecting antibodies to HIV1/2 and syphilis using a fingerstick blood sample.

Sponsors

Nova Scotia Health Authority
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Branch #1: Participants known to have an HIV infection - Inclusion criteria: • Previously documented positive HIV serology Branch #2: Participants known to have a history of syphilis infection - Inclusion criteria: • Documented positive syphilis serology Branch #3: Participants with no known HIV or syphilis infections - Inclusion criteria: • No documented positive HIV or syphilis serology

Exclusion criteria

Unable to speak and understand English

Design outcomes

Primary

MeasureTime frameDescription
Percent agreement of the INSTI HIV/syphilis POCT when used to self-test for antibodies to HIV 1/2 and syphilis when compared to conventional serologic results.Determined at the end of the implementation period (approximately 6 months).
Participant-rated clarity of instructional materials and satisfaction with INSTI HIV/syphilis self-testingImmediately after self-testing (Day 0)This measure includes two domains assessed immediately following completion of the self-test: 1. Instructional Clarity: Proportion of participants who agree, are neutral, or disagree with statements related to the clarity and usefulness of the video and infographic 2. Self-Test Satisfaction: Proportion of participants who agree, are neutral, or disagree with statements related to their satisfaction with the self-testing experience. Responses to Likert-style questions will be reported as percentages of participants selecting each category (agree, neutral, disagree) per question.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026